Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cerus Corp (CERS)

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,159,395
  • Shares Outstanding, K 163,988
  • Annual Sales, $ 93,770 K
  • Annual Income, $ -71,240 K
  • 60-Month Beta 1.29
  • Price/Sales 15.64
  • Price/Cash Flow N/A
  • Price/Book 10.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.59 +25.22%
on 06/11/20
7.49 -6.54%
on 07/07/20
+1.17 (+20.07%)
since 06/09/20
3-Month
4.87 +43.74%
on 04/15/20
7.49 -6.54%
on 07/07/20
+1.80 (+34.74%)
since 04/09/20
52-Week
2.71 +158.30%
on 03/18/20
7.49 -6.54%
on 07/07/20
+1.68 (+31.58%)
since 07/09/19

Most Recent Stories

More News
Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma

Cerus Corporation (Nasdaq:CERS) announced today study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative agent for COVID-19, in plasma components intended for transfusion....

CERS : 7.00 (-0.99%)
Zika Virus Vaccines Market 2027 Growth Opportunities, Top Key Players, Industry Outlook and Forecasts

Worldwide Analysis to 2027 is a specialized and in-depth study of the Zika Virus Vaccines Industry with a focus on the global market trend. The report aims to provide an overview of global Zika Virus...

CERS : 7.00 (-0.99%)
FSCR : 5.0000 (+11.11%)
GSK : 40.37 (-0.88%)
HON : 141.37 (-2.90%)
IMV.TO : 4.02 (+2.29%)
INO : 23.27 (-0.81%)
JGHAF : 17.3000 (unch)
NLNK : 0.8900 (-12.75%)
TKPYY : 16.5900 (-0.90%)
Is Cerus (CERS) Outperforming Other Medical Stocks This Year?

Is (CERS) Outperforming Other Medical Stocks This Year?

CERS : 7.00 (-0.99%)
Strong Retail Sales Bring Third Day of Gains

Strong Retail Sales Bring Third Day of Gains

CERS : 7.00 (-0.99%)
BBBY : 7.86 (-24.50%)
SPXS : 7.35 (+1.52%)
YEXT : 18.20 (+1.11%)
TTWO : 150.76 (+1.99%)
INCY : 107.87 (-0.37%)
APTV : 75.39 (-1.78%)
TJX : 49.99 (-1.73%)
XEC : 24.62 (-7.13%)
TMUS : 106.17 (-0.41%)
VFC : 58.27 (-3.97%)
WW : 23.66 (-2.55%)
LLY : 166.45 (-1.58%)
Cerus Corporation Celebrates World Blood Donor Day

Cerus Corporation (Nasdaq:CERS) celebrates World Blood Donor Day this Sunday, June 14, 2020. Enacted by the World Health Organization (WHO), World Blood Donor Day highlights the need for safe blood and...

CERS : 7.00 (-0.99%)
Cerus Corp Set to Possibly Rebound After Yesterday's Selloff of 1.46%

Cerus Corp (NASDAQ:CERS) traded in a range yesterday that spanned from a low of $5.68 to a high of $5.90. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $5.72 on...

CERS : 7.00 (-0.99%)
Watch for Cerus Corp to Potentially Pullback After Gaining 3.70% Yesterday

Cerus Corp (NASDAQ:CERS) traded in a range yesterday that spanned from a low of $6.18 to a high of $6.47. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $6.25...

CERS : 7.00 (-0.99%)
Cerus (CERS) Upgraded to Buy: What Does It Mean for the Stock?

Cerus (CERS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CERS : 7.00 (-0.99%)
Therapeutic Plasma Exchange Market Assessment 2015-2025: Includes Company Profilings of 15 Prominent Players

, /PRNewswire/ -- The report has been added to offering.

BAX : 85.69 (+1.79%)
CERS : 7.00 (-0.99%)
HEMA : 25.3100 (+0.60%)
KANKF : 28.1000 (unch)
Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex

Cerus Corporation (Nasdaq:CERS) announced today that the Company has submitted a pre-market approval supplement (PMA-S) to the FDA for a pathogen reduced cryoprecipitated fibrinogen complex with 5-day...

CERS : 7.00 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CERS with:

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

2nd Resistance Point 7.29
1st Resistance Point 7.15
Last Price 7.00
1st Support Level 6.84
2nd Support Level 6.67

See More

52-Week High 7.49
Last Price 7.00
Fibonacci 61.8% 5.66
Fibonacci 50% 5.10
Fibonacci 38.2% 4.54
52-Week Low 2.71

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar